Australia markets close in 4 hours 56 minutes

Astria Therapeutics Inc (209A.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.06600.0000 (0.00%)
At close: 08:37AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
49,820
42,127
34,264
15,552
25,590
-
Selling general and administrative
28,668
25,704
19,239
14,807
11,845
-
Total operating expenses
78,488
67,831
53,503
30,359
37,435
-
Operating income or loss
-78,488
-67,831
-53,503
-30,359
-37,435
-
Interest expense
-
-
-
-
-
0
Total other income/expenses net
-15,264
-15,261
-55
-164,675
-101
-
Income before tax
-81,631
-72,891
-51,834
-194,912
-37,300
-
Income from continuing operations
-81,631
-72,891
-51,834
-194,912
-37,300
-
Net income
-81,631
-72,891
-51,834
-194,912
-37,300
-
Net income available to common shareholders
-81,631
-72,891
-51,834
-219,349
-37,300
-
Basic EPS
-2.12
-2.42
-3.55
-24.58
-12.20
-
Diluted EPS
-2.12
-2.42
-3.55
-24.58
-12.20
-
Basic average shares
25,677
30,123
14,621
8,925
3,059
-
Diluted average shares
25,677
30,123
14,621
8,925
3,059
-